BMO Capital Markets reaffirmed their outperform rating on shares of Monsanto Co. (NYSE:MON) in a research report report published on Saturday. BMO Capital Markets currently has a $128.00 price objective on the stock.
Other equities analysts have also recently issued reports about the stock. Credit Agricole SA reaffirmed a buy rating on shares of Monsanto in a research report on Saturday, July 2nd. Vetr cut shares of Monsanto from a strong-buy rating to a buy rating and set a $116.47 target price for the company. in a research report on Thursday, July 14th. Deutsche Bank AG reissued a buy rating and issued a $118.00 target price on shares of Monsanto in a research report on Thursday, June 30th. Jefferies Group reissued a buy rating on shares of Monsanto in a research report on Wednesday, June 29th. Finally, Argus reissued a buy rating and issued a $128.00 target price (up previously from $111.00) on shares of Monsanto in a research report on Wednesday, June 15th. Three equities research analysts have rated the stock with a sell rating, eight have assigned a hold rating, fifteen have given a buy rating and one has issued a strong buy rating to the company. The company currently has a consensus rating of Buy and a consensus price target of $114.67.
Shares of Monsanto (NYSE:MON) opened at 103.36 on Friday. The firm’s 50-day moving average is $104.86 and its 200-day moving average is $101.43. Monsanto has a one year low of $83.73 and a one year high of $114.26. The company has a market cap of $45.23 billion, a price-to-earnings ratio of 45.49 and a beta of 1.19.
Monsanto (NYSE:MON) last released its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, topping the Zacks’ consensus estimate of ($0.02) by $0.09. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The firm earned $2.56 billion during the quarter, compared to analysts’ expectations of $2.38 billion. During the same period in the previous year, the business posted ($0.19) earnings per share. The company’s revenue for the quarter was up 8.8% compared to the same quarter last year. Analysts expect that Monsanto will post $4.89 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be given a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a dividend yield of 2.09%. The ex-dividend date is Wednesday, October 5th. Monsanto’s payout ratio is 71.05%.
In other news, CEO Michael K. Stern sold 12,797 shares of the company’s stock in a transaction that occurred on Wednesday, July 13th. The stock was sold at an average price of $101.77, for a total transaction of $1,302,350.69. Following the transaction, the chief executive officer now directly owns 21,583 shares of the company’s stock, valued at $2,196,501.91. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Brett D. Begemann sold 27,980 shares of the company’s stock in a transaction that occurred on Thursday, July 14th. The stock was sold at an average price of $103.62, for a total value of $2,899,287.60. Following the transaction, the chief operating officer now directly owns 102,480 shares in the company, valued at $10,618,977.60. The disclosure for this sale can be found here. Insiders own 0.88% of the company’s stock.
Several institutional investors have recently modified their holdings of the company. Vanguard Group Inc. raised its position in shares of Monsanto by 1.3% in the second quarter. Vanguard Group Inc. now owns 30,430,570 shares of the company’s stock worth $3,146,826,000 after buying an additional 389,914 shares during the last quarter. State Street Corp raised its position in shares of Monsanto by 0.9% in the first quarter. State Street Corp now owns 18,623,044 shares of the company’s stock worth $1,634,002,000 after buying an additional 173,201 shares during the last quarter. FMR LLC raised its position in shares of Monsanto by 41.3% in the second quarter. FMR LLC now owns 16,593,757 shares of the company’s stock worth $1,715,960,000 after buying an additional 4,851,499 shares during the last quarter. Massachusetts Financial Services Co. MA raised its position in shares of Monsanto by 0.3% in the second quarter. Massachusetts Financial Services Co. MA now owns 14,893,956 shares of the company’s stock worth $1,540,185,000 after buying an additional 38,316 shares during the last quarter. Finally, Capital International Investors raised its position in shares of Monsanto by 6.2% in the second quarter. Capital International Investors now owns 8,187,701 shares of the company’s stock worth $846,690,000 after buying an additional 476,848 shares during the last quarter. 79.02% of the stock is currently owned by institutional investors.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related companies with MarketBeat.com's FREE daily email newsletter.